New Zealand Society of Gastroenterology Guidelines for the Management of Refractory Ulcerative Colitis. [electronic resource]
- The New Zealand medical journal Oct 2015
- 63-76 p. digital
Publication Type: Journal Article; Practice Guideline
1175-8716
Adalimumab--therapeutic use Anti-Inflammatory Agents, Non-Steroidal--therapeutic use Antibodies, Monoclonal--therapeutic use Antibodies, Monoclonal, Humanized--therapeutic use Appendectomy Azathioprine--therapeutic use Colitis, Ulcerative--therapy Cyclosporine--therapeutic use Drug Resistance Drug Therapy, Combination Fecal Microbiota Transplantation Gastrointestinal Agents--therapeutic use Humans Immunosuppressive Agents--therapeutic use Infliximab--therapeutic use Leukapheresis Mercaptopurine--therapeutic use Mesalamine--therapeutic use Methotrexate--therapeutic use New Zealand Pediatrics Piperidines--therapeutic use Proctocolectomy, Restorative Protein Kinase Inhibitors--therapeutic use Pyrimidines--therapeutic use Pyrroles--therapeutic use Recurrence Severity of Illness Index Tacrolimus--therapeutic use Tumor Necrosis Factor-alpha--antagonists & inhibitors